Overview of predictive and prognostic biomarkers and their importance in developing a clinical pharmacology treatment plan in colorectal cancer patients is a research paper published in Expert Review of Clinical Pharmacology (2022). On theSindex it has a DataRank of 0.104. It has been cited 1 time.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.104
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institutes of Health
Grant: R01 CA204881
Defense Congressionally Directed Medical Research Program
Grant: W81XWH-19-1-0263
NCI NIH HHS
Grant: P30 CA056036
NCI NIH HHS
Grant: R01 CA204481
NIGMS NIH HHS
Grant: T32 GM008562
NCI NIH HHS
Grant: R01 CA206026
National Institutes of Health
Grant: 3P30CA056036-22S1
Strengthening Community Engagement in Colorectal Cancer Screening and Clinical Trial Enrollment Through a Community Health Educator
National Institutes of Health
Grant: 5R01CA206026-04
(PQ1) GUCY2C hormone loss translates APC-Beta-catenin mutations into epithelial transformation
Lorraine and David Swoyer
The Courtney Ann Diacont Memorial
West Pharmaceutical Services, Inc
NIH institutional award
Defense Congressionally Directed Medical Research Program
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals